JCM
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JCM Accepts, published online ahead of print on 20 December 2006
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.02221-06v1
45/2/501    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glupczynski, Y.
Right arrow Articles by Bogaerts, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glupczynski, Y.
Right arrow Articles by Bogaerts, P.

 Previous Article  |  Next Article 

J. Clin. Microbiol. doi:10.1128/JCM.02221-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Evaluation of a New Selective Chromogenic Agar Medium for detection of Extended-spectrum {beta}-lactamase-producing Enterobacteriaceae

Youri Glupczynski*, Catherine Berhin, Caroline Bauraing, and Pierre Bogaerts

Laboratoire de Bactériologie, Cliniques Universitaires UCL de Mont-Godinne, B-5530 Yvoir, Belgique

* To whom correspondence should be addressed. Email: youri.glupczynski{at}skynet. be.


   Abstract

A novel chromogenic agar medium (ESBL-Bx bioMérieux, Marcy L'Etoile, France) was compared to MacConkey agar supplemented with 2 mg ceftazidime/liter (MCKC) for the selective isolation and presumptive identification of extended-spectrum {beta}-lactamase (ESBL)-producing Enterobacteriaceae directly from clinical samples. Of a total of 644 clinical specimens (including 551 fecal samples), 496 yielded no growth and 148 yielded growth on one or both media. Overall, 44 ESBL-producing Enterobacteriaceae strains [Escherichia coli (n=17), Enterobacter aerogenes (n=17), Klebsiella spp. (n=5), Citrobacter freundii (n=5)] were isolated from 37 specimens by a combination of both methods after 18 to 24 h of incubation. The sensitivities were 97.7% and 84.1% for ESBL-Bx and MCKC, respectively with 43 ESBL-positive strains isolated as colored colonies from 36 specimens on ESBL-Bx versus 37 ESBL-positive organisms from 32 specimens on MCKC. The specificities by specimens were 89 and 91% for ESBL-Bx and MCKC, respectively. On any one of the two media, natural AmpC hyperproducing Enterobacter spp. (n=25) and Citrobacter spp. (n=14) were the most common false-positives as well as non-ESBL-producing Klebsiella oxytoca (n=18) on ESBL-Bx and Morganella morganii (n=10) on MCKC.

We conclude that ESBL-Bx is a sensitive and specific medium for the isolation of ESBL-producing Enterobacteriaceae from clinical samples. The main advantages of ESBL-Bx over MCKC reside in its chromogenic character and its sensitivity and selectivity which enabled the recovery and presumptive identification of most ESBL-producing Enterobacteriaceae within 24 h and reduced by 27% the need for unnecessary identification and confirmation of ESBL testing when disregarding all colorless colonies growing on this medium.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.